Skip to main content
ERNA logo

ERNA

Ernexa Therapeutics Inc.
$6.27 -0.43 (-6.42%) At close · Jul 2
Market Cap
$7.31M
Shares
1,166,333

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 20
Total Value: $730,863
Total Shares: 3,654,359

Institutional Ownership Trend

4 quarters

Holder Concentration

Across 20 13F filers · Δ vs Dec 31, 2025
Top Holder
56.0%
Jun 2025 → Mar 2026 · range 40.3% – 84.7%
−27.9 pts
Top 5
93.7%
Jun 2025 → Mar 2026 · range 93.7% – 99.5%
−5.8 pts
Top 10
98.6%
Jun 2025 → Mar 2026 · range 98.6% – 100.0%
−1.4 pts
HHI
3,630
Jun 2025 → Mar 2026 · range 3,271 – 7,243
Highly concentrated−3,472

Quarterly Activity

vs Dec 31, 2025
New
11
Increased
3
Decreased
0
Sold Out
5
Unchanged
6
Holder count: +6
Institutional value: +16.5%
Shares held: +599.1%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
No qualifying movers this quarter.

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 21 of 21
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 748592 CUSIP 114082308 Visit website Investor relations